Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.48%47.51M | 37.70%16.79M | -16.74%10.24M | -13.20%9.43M | -7.94%10.91M | 0.27%47.74M | -4.51%12.19M | 14.64%12.3M | -4.96%10.87M | -15.74%11.85M |
| Cost of revenue | -26.10%10.78M | -51.26%1.41M | -24.91%3.52M | -7.06%3.29M | -26.13%2.56M | -2.48%14.59M | -6.19%2.89M | 145.32%4.69M | -26.68%3.54M | -32.48%3.47M |
| Gross profit | 10.79%36.73M | 65.39%15.38M | -11.70%6.72M | -16.16%6.14M | -0.41%8.35M | 1.54%33.15M | -3.98%9.3M | -13.69%7.61M | 10.91%7.33M | -6.09%8.38M |
| Operating expense | -33.07%14.17M | -39.15%4.57M | -49.73%2.91M | -39.59%2.57M | 13.90%4.12M | 14.89%21.17M | 46.56%7.51M | 37.15%5.78M | 1.45%4.26M | -8.91%3.62M |
| Selling and administrative expenses | -33.07%14.17M | -39.15%4.57M | -49.73%2.91M | -39.59%2.57M | 13.90%4.12M | 20.90%21.17M | 46.56%7.51M | 37.15%5.78M | 1.45%4.26M | -8.91%3.62M |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -5.60%1.67M | ---- | ---- | ---- | ---- |
| -General and administrative expense | -33.07%14.17M | -39.15%4.57M | -49.73%2.91M | -39.59%2.57M | 13.90%4.12M | 34.48%21.17M | 46.56%7.51M | 37.15%5.78M | 1.45%4.26M | -8.91%3.62M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | -8.90%3.8M | ---- | ---- | ---- | ---- |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | -59.79%1.31M | ---- | ---- | ---- | ---- |
| Operating profit | 88.30%22.56M | 505.95%10.8M | 108.65%3.81M | 16.36%3.57M | -11.27%4.23M | -15.77%11.98M | -60.86%1.78M | -60.28%1.83M | 27.40%3.07M | -3.84%4.76M |
| Net non-operating interest income (expenses) | 5.54%-12.52M | -14.44%-3.28M | 12.54%-2.92M | 14.61%-2.86M | 6.48%-3.47M | 16.70%-13.25M | 26.37%-2.87M | 16.42%-3.33M | 15.65%-3.35M | 8.74%-3.71M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | --313K | ---- | ---- | ---- |
| Non-operating interest expense | -5.54%12.52M | 14.44%3.28M | -12.54%2.92M | -14.61%2.86M | -6.48%3.47M | -16.70%13.25M | -26.37%2.87M | -16.42%3.33M | -15.65%3.35M | -8.74%3.71M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Special income (charges) | 0 | -80.62%380.36K | -3.18M | 0 | ||||||
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | --3.18M | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | 80.62%-380.36K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -155.22%-9.71M | -750.00%-7.53M | -88.26%-834K | 34.13%-662K | 41.71%-545K | -3.81M | -15.06%-886K | 12.62%-443K | -159.05%-1.01M | -23.35%-935K |
| Income before tax | 106.44%327K | 99.54%-9K | 103.23%63K | 104.06%52K | 75.61%216K | -1,954.78%-5.08M | -1,691.82%-1.97M | -1,956.19%-1.95M | -990.28%-1.28M | -8.89%123K |
| Income tax | 30.97%2.33M | 37.55%2.33M | 0 | 0 | 0 | -19.92%1.78M | -20.65%1.69M | -6.67%28K | 0.00%28K | 0.00%29K |
| Net income | 70.84%-2M | 36.24%-2.34M | 103.19%63K | 103.97%52K | 129.79%216K | -252.64%-6.86M | -63.41%-3.66M | -2,736.00%-1.98M | -1,229.31%-1.31M | -11.32%94K |
| Net income continuous operations | 70.84%-2M | 36.24%-2.34M | 103.19%63K | 103.97%52K | 129.79%216K | -252.64%-6.86M | -63.41%-3.66M | -2,736.00%-1.98M | -1,229.31%-1.31M | -11.32%94K |
| Noncontrolling interests | 320.00%341K | 148.65%198K | -115.56%-291K | -91.30%6K | -20.13%254K | -132.14%-155K | -39.86%-407K | -141.28%-135K | -51.41%69K | 4.61%318K |
| Net income attributable to the company | 65.07%-2.34M | 22.18%-2.53M | 119.22%354K | 103.34%46K | 83.04%-38K | -176.15%-6.7M | -66.92%-3.26M | -630.95%-1.84M | -5,203.85%-1.38M | -13.13%-224K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 65.07%-2.34M | 22.18%-2.53M | 119.22%354K | 103.34%46K | 83.04%-38K | -176.15%-6.7M | -66.92%-3.26M | -630.95%-1.84M | -5,203.85%-1.38M | -13.13%-224K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 72.03%-0.004 | 37.68%-0.0043 | 117.95%0.0007 | 103.33%0.0001 | 80.00%-0.0001 | -150.88%-0.0143 | -50.00%-0.0069 | -550.00%-0.0039 | -2,900.00%-0.003 | 16.67%-0.0005 |
| Diluted earnings per share | 72.03%-0.004 | 38.57%-0.0043 | 117.95%0.0007 | 103.32%0.0001 | 80.00%-0.0001 | -150.88%-0.0143 | -52.17%-0.007 | -550.00%-0.0039 | -2,910.00%-0.003 | 16.67%-0.0005 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.